DDIT3 and COVID-19: The killing of memory lymphocytes by CHOP renders patients unable to establish long-term protective immunity following infection, increasing the risk of reinfection; meanwhile, in the immune-suppressed state, COVID-19 may progress to severe illness (e.g., acute respiratory distress syndrome [ARDS]).